149 related articles for article (PubMed ID: 28717948)
1. Evaluation of the Efficacy and Safety of an Imidacloprid 10 % / Moxidectin 1 % Spot-on Formulation (Advocate
Di Cesare A; Veronesi F; Capelli G; Deuster K; Schaper R; Basano FS; Nazzari R; Paoletti B; Traversa D
Parasitol Res; 2017 Aug; 116(Suppl 1):55-64. PubMed ID: 28717948
[No Abstract] [Full Text] [Related]
2. Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate
Veronesi F; Di Cesare A; Braun G; Günther L; Morganti G; Rueca F; Petry G; Schaper R; Traversa D
Parasitol Res; 2017 Aug; 116(Suppl 1):65-74. PubMed ID: 28717949
[No Abstract] [Full Text] [Related]
3. Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum.
Böhm C; Petry G; Schmidt H; Raue K; Barthel F; Schaper R
Parasitol Res; 2017 Aug; 116(Suppl 1):1-10. PubMed ID: 28717944
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline infection by Capillaria aerophila.
Traversa D; Di Cesare A; Di Giulio E; Castagna G; Schaper R; Braun G; Lohr B; Pampurini F; Milillo P; Strube K
Parasitol Res; 2012 Oct; 111(4):1793-8. PubMed ID: 22782476
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate
Diakou A; Morelli S; Dimzas D; Di Cesare A; Capelli G; Parrinello C; Pollmeier M; Schaper R; Traversa D
Parasit Vectors; 2019 Nov; 12(1):519. PubMed ID: 31685011
[TBL] [Abstract][Full Text] [Related]
6. The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in Europe.
Hellmann K; Knoppe T; Radeloff I; Heine J
Parasitol Res; 2003 Jul; 90 Suppl 3():S142-3. PubMed ID: 12928883
[No Abstract] [Full Text] [Related]
7. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats.
Otranto D; Solari Basano F; Pombi M; Capelli G; Nazzari R; Falsone L; Petry G; Pollmeier MG; Lia RP
Parasit Vectors; 2019 Jan; 12(1):25. PubMed ID: 30635002
[TBL] [Abstract][Full Text] [Related]
9. Treatment of naturally Notoedres cati-infested cats with a combination of imidacloprid 10 % / moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer).
Hellmann K; Petry G; Capari B; Cvejic D; Krämer F
Parasitol Res; 2013 Aug; 112 Suppl 1():57-66. PubMed ID: 23760872
[TBL] [Abstract][Full Text] [Related]
10. Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations.
Krüdewagen EM; Remer C; Deuster K; Schunack B; Wolken S; Crafford D; Fourie J; Stanneck D
Parasitol Res; 2015 Aug; 114 Suppl 1():S55-80. PubMed ID: 26152409
[TBL] [Abstract][Full Text] [Related]
11. Safety of imidacloprid plus moxidectin topical solution applied to cats heavily infected with adult heartworms (Dirofilaria immitis).
Arther RG; Atkins C; Ciszewski DK; Davis WL; Ensley SM; Settje TL
Parasitol Res; 2005 Oct; 97 Suppl 1():S70-S75. PubMed ID: 16228278
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a spot on combination containing imidacloprid 10% and moxidectin 1% (Advocate(®)/Advantage(®) Multi, Bayer Animal Health) against Ancylostoma ceylanicum in cats.
Taweethavonsawat P; Chungpivat S; Watanapongchati S; Traub RJ; Schaper R
Vet Parasitol; 2012 Nov; 190(1-2):289-93. PubMed ID: 22677133
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study.
Segev G; Rojas A; Lavy E; Yaffe M; Aroch I; Baneth G
Parasit Vectors; 2018 Mar; 11(1):127. PubMed ID: 29506575
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of a combination of imidacloprid and moxidectin against immature Toxocara catiin cats.
Reinemeyer CR; Charles S
Parasitol Res; 2003 Jul; 90 Suppl 3():S140-1. PubMed ID: 12928882
[No Abstract] [Full Text] [Related]
15. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
17. Microfilaricidal efficacy of a single administration of Advocate(®) (Bayer Animal Health) in dogs naturally infected with Dirofilaria immitis or Dirofilaria repens.
Frangipane di Regalbono A; Di Cesare A; Traversa D; Simonato G; Poser H; Danesi P; Furnari C; Russi I; Raele DA; Crisi P; Pampurini F; Pietrobelli M
Vet Parasitol; 2016 Aug; 226():30-4. PubMed ID: 27514879
[TBL] [Abstract][Full Text] [Related]
18. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
Bowman DD; Charles SD; Arther RG; Settje T
Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis.
Traversa D; Di Cesare A; Milillo P; Lohr B; Iorio R; Pampurini F; Schaper R; Paoletti B; Heine J
Parasitol Res; 2009 Aug; 105 Suppl 1():S55-62. PubMed ID: 19575226
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
